Abstract:Background 'Periodontitis' refers to periodontal destruction of connective tissue attachment and bone, in response to microorganisms forming subgingival biofilms on the root surface, while 'apical periodontitis' refers to periapical inflammatory processes occurring in response to microorganisms within the root canal system. The treatment of both diseases is based on the elimination of the bacterial challenge, though its predictability depends on the ability of disrupting these biofilms, what may need adjunctive antibacterial strategies, such as the next‐generation antibacterial strategies (NGAS). From all the newly developed NGAS, the use of polymeric nanotechnology may pose a potential effective approach. Although some of these strategies have only been tested in vitro and in preclinical in vivo models, their use holds a great potential, and therefore, it is relevant to understand their mechanism of action and evaluate their scientific evidence of efficacy. Objectives To explore NGAS based on polymeric nanotechnology used for the potential treatment of periodontitis and apical periodontitis. Method A systemic search of scientific publications of adjunctive antimicrobial strategies using nanopolymers to treat periodontal and periapical diseases was conducted using The National Library of Medicine (MEDLINE by PubMed), The Cochrane Oral Health Group Trials Register, EMBASE and Web of Science. Results Different polymeric nanoparticles, nanofibres and nanostructured hydrogels combined with antimicrobial substances have been identified in the periodontal literature, being the most commonly used nanopolymers of polycaprolactone, poly(lactic‐co‐glycolic acid) and chitosan. As antimicrobials, the most frequently used have been antibiotics, though other antimicrobial substances, such as metallic ions, peptides and naturally derived products, have also been added to the nanopolymers. Conclusion Polymeric nanomaterials containing antimicrobial compounds may be considered as a potential NGAS. Its relative efficacy, however, is not well understood since most of the existing evidence is derived from in vitro or preclinical in vivo studies.

Nanoparticles in Periodontitis Therapy: A Review of the Current Situation

Nanomaterials: innovative approaches for addressing key objectives in periodontitis treatment

New insights into nanotherapeutics for periodontitis: a triple concerto of antimicrobial activity, immunomodulation and periodontium regeneration

Nanoparticle-Hydrogel composites: Research progress in the treatment of periodontitis

Advanced biomaterials and their potential applications in the treatment of periodontal disease

Recent advances in metal nanoparticles to treat periodontitis

Nano-Based Drug Delivery Systems for Periodontal Tissue Regeneration

Functional biomaterials for comprehensive periodontitis therapy

ROS-Scavenging Nanomaterials to Treat Periodontitis

Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects

Immunomodulatory nanotherapeutic approaches for periodontal tissue regeneration

Herbal and nano-based herbal medicine: New insights into their therapeutic aspects against periodontitis

Research Progress on Nanomaterials for Tissue Engineering in Oral Diseases

Novel Bioactive and Therapeutic Dental Polymeric Materials to Inhibit Periodontal Pathogens and Biofilms

Pathology‐Guided Cell Membrane‐Coated Polydopamine Nanoparticles for Efficient Multisynergistic Treatment of Periodontitis

Integrating enzyme-nanoparticles bring new prospects for the diagnosis and treatment of immune dysregulation in periodontitis

Global research trends of nanomaterials application in periodontitis and peri-implantitis: A bibliometric analysis

The Emerging Role of Plant-Derived Exosomes-Like Nanoparticles in Immune Regulation and Periodontitis Treatment

Versatile hybrid nanoplatforms for treating periodontitis with chemical/photothermal therapy and reactive oxygen species scavenging

Analysis of the Therapeutic Effect of Nano-Silver on Periodontitis and Its Influence on Disease Recurrence

Next‐generation antibacterial nanopolymers for treating oral chronic inflammatory diseases of bacterial origin